Ads
related to: merck & co- Astellas Pharma Support
Learn about our Support Solutions
and find helpful enrollment forms.
- World-Class Products
Discover more about our FDA-
approved treatment options.
- Science and Innovation
View our approach to finding
solutions for cancer's complexities
- Patient Commitment
Our Patient Centricity Team aims to
change the course of cancer care.
- Astellas Pharma Support
Search results
Top Stock Reports for Broadcom, Merck & Airbnb
Zacks via Yahoo Finance· 7 days agoToday's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Merck & Co., Inc. (MRK) and Airbnb, Inc. (ABNB).
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 20 hours agoImfinzi, the company’s flagship immunotherapy, arrived fifth to market in the U.S. and last year...
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 24 hours agoBristol Myers Squibb and Novartis, the latter of which has two approved radiopharmaceuticals,...
Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal
FierceBiotech· 1 day agoEli Lilly is continuing to ride the radiopharma wave, paying Aktis Oncology $60 million upfront to...
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 1 day agoTwo of 2023’s largest acquisitions — Roche’s $7.1 billion acquisition of Telavant and Merck & Co.’s...
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
Digital Journal· 2 hours agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it ...
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks· 6 days agoStocks recently featured in the blog include: Broadcom Inc. (AVGO Quick QuoteAVGO - Free Report) , Merck & Co., Inc. (MRK Quick QuoteMRK - Free Report) ...
Scott Black's Strategic Moves in Q4 2023: Spotlight on WR Berkley Corp
GuruFocus.com via Yahoo Finance· 2 days agoThe Walt Disney Co (NYSE:DIS) with 15,767 shares, representing about 1.3% of the portfolio, valued...
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential
FierceBiotech· 7 days agoWhat a time to be launching a new biotech focused on inflammation and immunology. Uniquity Bio is...
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks· 6 days agoPharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH Quick QuoteXPH - Free Report) is a passively managed exchange traded fund launched on 06/19/2006. While an excellent ...